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Abstract
The aim of our work was to study the neurological status and cognitive function in patients with stage I and II CCI, 
depending on its nature. 
Material and Methods: The study included 302 patients (mean age - 61.3±0.3 years; 165/54.6% men and 137/45.4% 
women) with stage I and II CCI. Clinical and neurological examination, study of cognitive function, and MRI were performed in 
all patients. The degree of cognitive defect was determined by the MMSE (Mini-Mental State Exam) test and the Bourdon test 
(visual perception and vigilance). All the subjects were categorized into two groups. Group 1 consisted of 133 patients with the 
amnestic type of MCI (AT-MCI); Group 2 consisted of 169 patients with the multifunction type of MCI (MT-MCI). 
Results: The highest frequency of complaints of a cerebral nature was observed in Group 2 patients with MT-MCI compared 
to Group 1 patients with AT-MCI. It should be noted that memory impairment occurred in all patients in Group 1. The clinical-
neurological examination revealed that the subjective complaints of a cerebral nature occurred significantly more frequently in 
Group 2 patients compared with Group 1 patients, except for the memory disorders, which prevailed in Group 1 patients with 
AT-MCI. With regard to the objective symptoms, the focal neurological symptoms occurred with equal frequency in both groups. 
It should be noted that the symptoms of the carotid region were more frequent in Group 2 patients and the symptoms of the 
vertebrobasilar region in Group 1 patients. The parameters of the cognitive function related to the concentration and stability 
of attention were less disturbed in patients with AT-MCI compared with the patients having the MT-MCI, and those parameters 
correlated with the parameters of the neurological focal symptoms.
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Introduction
Chronic cerebral ischemia (CCI) is one of the main 
causes of dementia in elderly people. Several European studies 
have demonstrated the prevalence of vascular dementia (VD) 
in 1.6% of people over 65 years of age [1,2]. It is noted that the 
prevalence and severity of VD tends toward sustainedgrowth 
with age. In studies with autopsy, VD was detected in 20% of 
patients [3,4]. 
In most cases, CCI is developed on the background 
of hypertension and atherosclerotic vascular lesions of the 
brain. Risk factors for VD and CCI are diabetes, hypertension, 
genotype of ApoE gene (E4), and smoking [5,6]. These risk 
factors have a direct effect on blood vessels and vascular 
function. In one of the studies of risk factors for VD (smoking, 
hypertension and diabetes), they were closely associated with 
the subsequent risk of hospitalization for cognitive decline; this 
is seen most clearly in middle-aged patients. This association 
was stronger when risk factors were assessed at a young age 
and again at a later age [7].
Impaired cognition that is associated with CCI can vary 
from “central” deficit (aphasia, visual agnosia or ignoring the 
neurological defect) to disorders of cognitive functions in the 
framework for dementia (from subclinical to coarse disorders) 
[5,8,9]. Unlike neurodegenerative diseases such as Alzheimer’s 
disease, there is not a single profile for cognitive disorders that 
would characterize VD. The most common manifestation of 
VD is cognitive deficit, which is more apparent than mental 
disorders [10-13].
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Thus, recognition of causes, identifying risk factors, 
and the exact knowledge of the structural, physiological 
and clinical features of the disease define the real possibility 
for effective treatment and prevention of chronic vascular 
pathology of the brain.
Based on the above, the aim of this work was to study 
the neurological status and cognitive function in patients with 
stage I and II CCI, depending on its nature.
Material and Methods
We present results of a comprehensive survey of 302 
patients (165/54.6%  men and 137/45.4% women) with stage 
I and II CCI, who were hospitalized in the department of 
neurology of RCH #1, CCH “Uzbekistan Temir Iulary”, private 
hospital “Spectra neurology “ named after Academician NM 
Madjidov”,  GMS  and “NeuroMed-service” hospitals during 
2010–2013. Written informed consent was obtained from each 
patient.
Among  those  surveyed,  male  patients  significantly 
predominated over women. The mean age was 61.3±0.3 
years. Patients aged from 60 to 69 years composed the largest 
group (n=225/74.5%), and patients aged from 43 to 49 years 
composed the smallest group (n=5/1.7%). Table 1 shows the 
distribution of patients by age and sex. It may be noted that 
the development of mild cognitive impairment (MCI) was 
associated with age and gender; so, the risk of this disease 
increases in men with increasing age.
The diagnosis of MCI was verified according to ICD-
10. Clinical and neurological examination, study of cognitive 
function, and MRI were performed in all patients. The 
degree of cognitive defect was determined by the MMSE 
(Mini-Mental State Exam) test and the Bourdon test (visual 
perception and vigilance). The distribution of patients into 
groups was done according to the classification of O.S. Levin 
(2010). Group 1 consisted of 133 patients with the amnestic 
type of MCI (AT-MCI); Group 2 consisted of 169 patients 
with the multifunction type of MCI (MT-MCI). Analysis of 
the age and sex gradation revealed that the AT-MCI and MT-
MCI were more common among men over the age of 60 years.
The exclusion criteria were age less than 35 and older 
than 75 years, CCI stage III, other etiologies of encephalopathy, 
stroke , diabetes , epilepsy, organic diseases of the brain and 
spinal cord (the hereditary, demyelinating,  and degenerative 
diseases, tumors), blood diseases and autoimmune diseases. 
Control group included 30 healthy subjects without any 
objective manifestations of CCI.
Statistical analysis was performed using the statistical 
software «Statistica». For data with normal distribution, inter-
group comparisons were performed using student’s t-test. 
The mean (M) and standard error of the mean (SEM) were 
calculated. The difference was considered reliable when 
P<0.05.
Results and Discussion
The main subjective symptoms (Table 2) were 
headache, dizziness, tinnitus, a decrease of memory and 
attention, disorders in the emotional sphere, and decreased 
performance. Therefore, a headache was more frequent in 
the Group 2 patients compared to the Group 1 patients. An 
unsystematic dizziness was also more frequent in patients in 
Group 2 compared to patients in Group 1.  Decreased memory 
was found in 133 (100%) patients in Group 1 and 145 (86.8%) 
patients in Group 2. Fatigue and decreased performance took 
place in 100 (76.9%) and 123 (92.4%) patients in Group 1 and 
134 (80.2%) and 141 (84.4%) patients in Group 2, respectively. 
These symptoms were associated with decreased attention in 
123 (92.4%) patients in Group 1 and 142 (85%) patients in 
Group 2. Sleep disturbance took place in 102 (76.6%) patients 
in Group 1 and 140 (83.8%) patients in Group 2. Tinnitus 
occurred in 89 (66.9%) patients in Group 1 and 125 (74.8%) 
patients in Group 2. As can be seen from the presented data, 
the highest frequency of complaints of a cerebral nature was 
observed in Group 2 patients with MT-MCI compared to 
Group 1 patients with AT-MCI. It should be noted that memory 
impairment occurred in all patients in Group 1. 
We also conducted an analysis of the focal neurological 
symptoms. As can be seen from Table 3, the central paresis 
of the cranial nerve VII was detected in 124 (93.2%) patients 
in Group1 and 146 (87.4%) in Group 2. The central paresis 
of the cranial nerve XII occurred in 86 (64.6%) patients 
in Group 1 and 123 (73.6%) patients in Group 2. Reduced 
convergence and weakness of accommodation were identified 
in 80 (60.0%) patients in Group 1 and 101(60.4%) patients 
in Group 2. Reflexes of oral automatism were noted in 96 
(72.1%) patients in Group 1 and 129 (77.2%) patients in Group 
2. Aniso-reflection was diagnosed in 83 (62.4%) patients in 
Group 1 and 112 (67%) patients in Group 2. Symptoms of 
the carotid region took place more frequently in the Group 2 
patients, but the focal symptoms of the vertebrobasilar region 
were more frequent in the Group 1 patients. Thus, instability 
Table 1.
Distribution of patients by age and sex
Group
Sex  Age (yrs)
Men Women Mean
 age
43-49 50-59 60-69                                                                                                       
n % n % n % n % n %
Group 1 74 55.6 59 44.4 61.6±0.45 3 2.3 28 21.0 102 76.7
Group 2  91 53.8 78 46.2 61.1±0.39 2 1.2 44 25.4 123 73.4
Total  165 54.6 137 45.4 61.3±0.3 5 1.7 72 23.8 225 74.5
Table 2.
Semiological features of symptoms of cerebral nature 
Subjective
 symptoms
Group1 (n=133) Group 2 (n=167) 
Р
Abs. % Abs. %
Headache 79 59.4±4.2 135 80.8±3.0 <0.001
Dizziness 46 34.6±4.1 129 77.2±32 <0.001
Decrease of memory 133 100 145 86.8±2.6 <0.01
Fatigue 130 97.7±1.3 134 80.2±3.1 <0.001
Decreased performance 100 75.2±3.7 141 84.4±2.8 <0.05
Decreased attention 123 92.4±2.3 142 85.0±2.8 <0.05
Sleep disturbance 102 76.7±3.7 140 83.8±2.8 >0.05
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in the Romberg pose was observed in 87 (65.4%) patients in 
Group 1 and 102 (61%) patients in Group 2. Many patients 
had violations when performing the tests for coordination. 
In Group 1, an intention tremor in the finger-nose test was 
observed in 69 (51.8%) patients and an abnormality in the 
heel-knee-shin tests occurred in 39 (29.3%) patients. These 
disturbances  were  ‘identified  in  82(49.1%)  patients  and 
41(24.5%) patients in Group 2. At the same time, differences 
between the two groups were not significant.
The clinical-neurological examination revealed that the 
subjective complaints of a cerebral nature occurred significantly 
more frequently in Group 2 patients compared with Group 1 
patients, except for the memory disorders, which prevailed in 
Group 1 patients with AT-MCI. With regard to the objective 
symptoms, the focal neurological symptoms occurred with 
equal frequency in both groups. It should be noted that the 
symptoms of the carotid region were more frequent in Group 
2 patients and the symptoms of the vertebrobasilar region in 
Group 1 patients.
We analyzed the results of the psychological tests 
regarding the cognitive sphere in the CCI patients and the 
correlations between these parameters and the indicators of 
neurological status. The MMSE score was 24.8±0.1 points in 
Group 1 patients versus 23.4±0.15 in Group 2 patients that 
correspond to MCI in both groups (Table 4). The analysis of 
the correlations between the severity of cognitive impairment 
on the MMSE and the objective focal symptoms revealed the 
following features: An inverse correlation was found between 
the severity of cognitive impairment and the central paresis 
of cranial nerves VII and XII (r = -0.565), as well as with the 
reflexes of oral automatism (r = -0.455). 
The Bourdon test revealed a decline in the concentration 
and stability of attention in both groups. In the studied patients, 
the level of the concentration of attention was 144.6±1.34 
points and the sustained attention - 3.5±0.01 points; these 
values     were significantly lower in comparison with the control 
values. In Group 2 patients, the concentration of attention 
was 124.2±1.18 points, and the sustained attention 3.4±0.03 
points; these indexes were significantly lower compared with 
indexes of the control group and Group 1 (Table 5).
Correlations were also found with the central paresis of 
the cranial nerves VII and XII, the reflexes of oral automatism, 
and the aniso-reflection. In Group 2 patients, there were also 
correlations with the decreased convergence and the weakness 
of accommodation.
Thus, the parameters of the cognitive function related to 
the concentration and stability of attention were less disturbed 
in patients with AT-MCI compared with the patients having the 
MT-MCI, and those parameters correlated with the parameters 
of the neurological focal symptoms.
Conclusion
In conclusion, it should be noted that the development 
of cognitive impairment in patients with CCI is caused by 
the phenomena of cortical-subcortical and cortical-cortical 
dissociation (disconnection syndrome), which are often 
detected in CCI. In the disconnection syndrome, lesions of 
the association pathways between the various parts of the 
brain are observed, which lead to the delay and reduction of 
intellectual-mental functions.
We revealed that cognitive deficits are predominant in 
patients with MT-MCI compared with patients having AT-
MCI. This is proved by a number of psychological studies, 
including classical and modern tests, and allows us to 
differentiate the dementia of the Alzheimer type from vascular 
type. Carrying out these tests in clinical practice will allow 
diagnosis of the pre-dementia disorders in patients with CCI.
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